共 1 页 当前第 1 页 返回检索页| 1 | 药品名称 | DELCOBESE |
| 申请号 | 083563 | 产品号 | 001 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 5MG;5MG;5MG;5MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 2 | 药品名称 | DELCOBESE |
| 申请号 | 083563 | 产品号 | 002 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 3.75MG;3.75MG;3.75MG;3.75MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 3 | 药品名称 | DELCOBESE |
| 申请号 | 083563 | 产品号 | 003 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 2.5MG;2.5MG;2.5MG;2.5MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 4 | 药品名称 | DELCOBESE |
| 申请号 | 083563 | 产品号 | 004 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 1.25MG;1.25MG;1.25MG;1.25MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 5 | 药品名称 | DELCOBESE |
| 申请号 | 083564 | 产品号 | 001 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | CAPSULE;ORAL | 规格 | 1.25MG;1.25MG;1.25MG;1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 6 | 药品名称 | DELCOBESE |
| 申请号 | 083564 | 产品号 | 002 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | CAPSULE;ORAL | 规格 | 2.5MG;2.5MG;2.5MG;2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 7 | 药品名称 | DELCOBESE |
| 申请号 | 083564 | 产品号 | 003 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | CAPSULE;ORAL | 规格 | 3.75MG;3.75MG;3.75MG;3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|
| 8 | 药品名称 | DELCOBESE |
| 申请号 | 083564 | 产品号 | 004 |
| 活性成分 | AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | CAPSULE;ORAL | 规格 | 5MG;5MG;5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | TEVA PHARMACEUTICALS USA INC
|